Clinical trial

Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP)

NCT01103089

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2010-03-01

PhaseN/A

Study timeline

Study start (unknown)2010-03-01Date precision: month

Registry last updated2011-10-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-Small Cell Lung Cancerverified · MONDO: non-small cell lung carcinoma

Interventions

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

AmsterdamNetherlands1 GroningenNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01103089 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.